Home › Funds › PSP Research LLC › TARS
PSP Research LLC position in TARS
TARSUS PHARMACEUTICALS INC · Health Care
PSP Research LLC reported holding 3,500 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$275K, representing 0.19% of its reported portfolio and ranking #11 among its reported holdings. PSP Research LLC has disclosed TARS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How PSP Research LLC's TARS position evolved
PSP Research LLC first disclosed a stake in TARS in Q4 2025 at 6,519 shares (US$534K). Across 4 filings, PSP Research LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,500 shares valued at US$275K — a reduction of -3,500 shares quarter over quarter.. Notable position changes include a 50% trim in Q3 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 6.52K | $533.78K | New |
| Q1 2026 | 7.00K | $491.05K | Add |
| Q2 2026 | 7.00K | $440.58K | Hold |
| Q3 2026 | 3.50K | $275.13K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TARS and 13F data
TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$230.8M), RTW INVESTMENTS, LP (US$211.3M), Paradigm Biocapital Advisors LP (US$174.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TARS
- Deep Track Capital, LP 3.67M sh · $230.79M · Q2 2026
- RTW INVESTMENTS, LP 3.36M sh · $211.29M · Q2 2026
- Paradigm Biocapital Advisors LP 2.78M sh · $174.70M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.57M sh · $98.71M · Q2 2026
- Vestal Point Capital, LP 1.05M sh · $66.09M · Q2 2026
- Frazier Life Sciences Management, L.P. 728.64K sh · $45.86M · Q2 2026
- Tri Locum Partners LP 328.34K sh · $20.67M · Q2 2026
- MPM BioImpact LLC 322.01K sh · $20.27M · Q2 2026
More on PSP Research LLC
FAQ
How long has PSP Research LLC held TARS?
PSP Research LLC has disclosed TARS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is PSP Research LLC's current position in TARS?
As of Q3 2026, PSP Research LLC holds 3.50K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $275.13K, representing 0.19% of its reported portfolio and ranking #11.
Has PSP Research LLC been buying or selling TARS?
In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in TARS.
Which other funds hold TARS?
Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.